Luc Friboulet
23PUBLICATIONS
163CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (23)
Sort by Publication Date:
|Feb 03, 2026
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé
|Apr 16, 2025
<i>BRAF</i> Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With <i>BRAF</i><sup>V600E</sup>-Mutated Lung Adenocarcinoma.Pierre de Priester, Lodovica Zullo, Damien Vasseur
|Oct 31, 2024
Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancer.Yohann Loriot, Maud Kamal, Laurene Syx
|Oct 04, 2024
The genomic and transcriptomic landscape of metastastic urothelial cancer.Yohann Loriot, Maud Kamal, Laurene Syx
|Sep 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations.Jessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul
|Sep 03, 2024
Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies.Francesco Facchinetti, Yohann Loriot, Floriane Brayé
Pageof 4
Frequent Collaborators
10 joint publications
Benjamin Besse
8 joint publications
Antoine Hollebecque
8 joint publications
Yohann Loriot
7 joint publications
Ludovic Lacroix
7 joint publications
Fabrice Andre
6 joint publications
Ludovic Bigot
6 joint publications
Jean-Yves Scoazec
6 joint publications
Lambros Tselikas
6 joint publications
Stefan Michiels
5 joint publications
Damien Vasseur
